Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Measuring the minimum clinically important difference in BPH outcome measures.

John E. Mahoney1, William L. Orovan, Richard Casey

  • 1Assistant Professor, University of Ottawa, Ottawa General Hospital, Ottawa, Ontario.

The Canadian Journal of Urology
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Everything old is new again.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2020
Same author

Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2020
Same author

Why do we ignore our existing talent pool?

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2020
Same author

How I Do It - MRI-ultrasound fusion prostate biopsy using the Fusion MR and Fusion Bx systems.

The Canadian journal of urology·2020
Same author

A "shocking" word.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2020
Same author

The Primary Care Provider (Family Physician and Nurse Practitioner)-Specialist: Partnership.

The Canadian journal of urology·2020
Same journal

Smarter, Not More: The Rationale for Reducing Systematic Cores in the MRI-Targeted Biopsy Era.

The Canadian journal of urology·2026
Same journal

Ten Years of Progress in Advanced Prostate Cancer at the AUA.

The Canadian journal of urology·2026
Same journal

Electroacupuncture for sperm improvement in varicocele: a case report.

The Canadian journal of urology·2026
Same journal

Transperineal approach for penetrating injury of corpus spongiosum and bulbous urethra caused by vesicourethral foreign body: a case report.

The Canadian journal of urology·2026
Same journal

Penile fracture and concomitant severe urethral trauma-a case report and discussion of surgical approach.

The Canadian journal of urology·2026
Same journal

Management of retained bullet fragments from posterior urethra after gunshot wound: a case report.

The Canadian journal of urology·2026
See all related articles

The Boyarsky score best reflects patient-reported improvement in benign prostatic hyperplasia (BPH) symptoms. Other measures like flow rates showed no significant correlation with patient-perceived treatment effectiveness.

Area of Science:

  • Urology
  • Clinical Research
  • Patient-Reported Outcomes

Background:

  • Benign prostatic hyperplasia (BPH) is a common condition affecting many men.
  • Standardized outcome measures are crucial for evaluating BPH treatments.
  • Determining the minimum clinically important difference (MCID) is essential for interpreting research findings.

Purpose of the Study:

  • To identify the most clinically meaningful outcome measures in benign prostatic hyperplasia (BPH) research.
  • To establish the minimum clinically important difference (MCID) for various BPH assessment tools.
  • To correlate objective BPH measures with subjective patient improvement ratings.

Main Methods:

  • Prospective recruitment of 42 patients with symptomatic BPH from urology clinics.

Related Experiment Videos

  • Utilized a self-administered questionnaire for patients to rate their improvement.
  • Compared patient-reported improvement scores with changes in established outcome measures from baseline.

    • Main Results:

    • Maximum and mean flow rates did not significantly correlate with patient-reported improvement.
    • The Boyarsky score demonstrated the strongest correlation with the patient's overall improvement grading (R=.507, p<.001).
    • Patients reporting slight improvement showed a mean change of 3.23 (sd=3.52) in their Boyarsky symptom score.

    Conclusions:

    • The Boyarsky score appears to be a more sensitive indicator of clinically meaningful change in BPH than flow rate measurements.
    • Future BPH research should consider incorporating the Boyarsky score to better align with patient-perceived outcomes.
    • Establishing MCID for BPH outcome measures requires validation against patient-reported satisfaction and improvement.